PPP1CA and neoplasm: In hepatocellular carcinoma, miR‐449a‐5p enhances the anti‐tumour effects of sorafenib by down‐regulating PPP1CA, including inhibiting cell proliferation and angiogenesis and inducing apoptosis [37].